Daniel Barber
2023
In 2023, Daniel Barber earned a total compensation of $2.5M as Chief Executive Officer at Aquestive Therapeutics, a 88% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $435,600 |
---|---|
Salary | $600,000 |
Stock Awards | $1,432,635 |
Other | $27,906 |
Total | $2,496,141 |
Barber received $1.4M in stock awards, accounting for 57% of the total pay in 2023.
Barber also received $435.6K in non-equity incentive plan, $600K in salary and $27.9K in other compensation.
Rankings
In 2023, Daniel Barber's compensation ranked 395th out of 2,983 executives tracked by ExecPay. In other words, Barber earned more than 86.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 395 | 87th |
Manufacturing | 226 | 86th |
Chemicals And Allied Products | 158 | 83rd |
Drugs | 155 | 82nd |
Pharmaceutical Preparations | 95 | 85th |
Barber's colleagues
We found two more compensation records of executives who worked with Daniel Barber at Aquestive Therapeutics in 2023.
News
Aquestive Therapeutics CEO Daniel Barber's 2023 pay jumps 88% to $2.5M
April 26, 2024
Aquestive Therapeutics CEO Keith Kendall's 2021 pay jumps 59% to $2M
April 29, 2022
Aquestive Therapeutics CFO John Maxwell's 2020 pay jumps 24% to $1.3M
May 5, 2021
Aquestive Therapeutics CEO Keith Kendall's 2019 pay falls 67% to $2.6M
April 29, 2020